glp 1 agonists for type 2 diabetes GLP-1 receptor in the treatment of – state-of-the-art GLP1 Receptor Agonists vs SGLT2-I

GIP and GLP-1 exert their effects by binding to their specific receptors, GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), both belonging to the G protein-coupled receptor family

7LLL: Deganutti G, Liang YL, Zhang X, Khoshouei M, Clydesdale L, Belousoff MJ, Venugopal H, Truong TT, Glukhova A, Keller AN, Gregory KJ, Leach K, Christopoulos A, Danev R, Reynolds CA, Zhao P, Sexton PM, Wootten D

and bremelanotide, a melanocortin 4 receptor agonist (NCT06565611)

The early evidence shows that both approaches are effective, but they offer different advantages depending on health needs, treatment goals, and personal preference

Expression of the Glucagon-Like Peptide-1 Receptor and Its Role in Regulating Autophagy in Endometrial Cancer